Acute activation of metabolic syndrome components in pediatric acute lymphoblastic leukemia patients treated with dexamethasone

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Warris, Lidewij T ^a,f   Van Den Akker, Erica L T ^a   Bierings, Marc B ^d,f   Van Bos, Cor Den ^b   Zwaan, Christian M ^a   Sassen, Sebastiaan D T ^a   Tissing, Wim J E ^e   Veening, Margreet A ^c   Pieters, Rob ^f   Van Den Heuvel Eibrink, Marry M ^a,f  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f Department of Radiation Oncology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DEXAMETHASONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; MERCAPTOPURINE; METHOTREXATE; TRIACYLGLYCEROL; VINCRISTINE; BIOLOGICAL MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVOR; CARDIOVASCULAR RISK; CHILD; CHILDHOOD LEUKEMIA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY (TOPIC); OBESITY; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; CHEMICALLY INDUCED; CONTROLLED STUDY; MAINTENANCE CHEMOTHERAPY; METABOLISM; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DEXAMETHASONE; FEMALE; GLUCOSE; HUMANS; INSULIN; MAINTENANCE CHEMOTHERAPY; MALE; METABOLIC SYNDROME X; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 84977497336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158225     Document Type: Article

References (46)

1. Veerman AJ, Kamps WA, van den Berg H, van den Berg E, Bokkerink JP, Bruin MC, et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol. 2009; 10: 957-966.doi: 10.1016/S1470-2045(09)70228-1 PMID: 19747876
2. Belgaumi AF, Al-Bakrah M, Al-Mahr M, Al-Jefri A, Al-Musa A, Saleh M, et al. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer. 2003; 97: 2898-2903. PMID: 12767105
3. Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A, Gibson BE. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2001; 86: 3742-3745. PMID: 11502805
4. Ahmed SF, Tucker P, Mushtaq T, Wallace AM, Williams DM, Hughes IA. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone. Clin Endocrinol. 2002; 57: 185-191.
5. Mattano LA Jr, Devidas M, Nachman JB, Sather HN, Hunger SP, Steinherz PG, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012; 13: 906-915. PMID: 22901620
6. Chow EJ, Pihoker C, Friedman DL, Lee SJ, McCune JS, Wharton C, et al. Glucocorticoids and Insulin Resistance in Children With Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2013; 60: 621-626.
7. Kamdem LK, Hamilton L, Cheng C, Liu W, Yang W, Johnson JA, et al. Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2008; 18: 507-514. PMID: 18496130
8. Lowas SR, Marks D, Malempati S. Prevalence of Transient Hyperglycemia During Induction Chemotherapy for Pediatric Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2009; 52: 814-818.
9. McGrath P, Rawson-Huff N. Corticosteroids during continuation therapy for acute lymphoblastic leukemia: the psycho-social impact. Issues Compr Pediatr Nurs. 2010; 33: 5-19. doi: 10.3109/01460860903486572 PMID: 20121577
10. Jung HS, Myung SK, Kim BS, Seo HG. Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract. 2012; 95: 275-282. doi: 10.1016/j.diabres.2011.08.029 PMID: 22078073
11. Karakurt H, Sarper N, Kilic SC, Gelen SA, Zengin E. Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance. Pediatr Hematol Oncol. 2012; 29: 551-561. doi: 10.3109/08880018.2012.708892 PMID: 22897748
12. Abu-Ouf NM, Jan MM. Metabolic syndrome in the survivors of childhood acute lymphoblastic leukaemia. Obes Res Clin Pract. 2015; 9: 114-124. doi: 10.1016/j.orcp.2014.06.004 PMID: 25081809
13. Kero AE, Madanat-Harjuoja LM, Jarvela LS, Malila N, Matomaki J, Lahteenmaki PM. Health conditions associated with metabolic syndrome after cancer at a young age: A nationwide register-based study. Cancer epidemiology. 2016; 41: 42-49. doi: 10.1016/j.canep.2016.01.009 PMID: 26816350
14. Nottage KA, Ness KK, Li CH, Srivastava D, Robison LL, Hudson MM. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia-From the St. Jude Lifetime Cohort. Brit J Haematol. 2014; 165: 364-374.
15. Wallace AM, Tucker P, Williams DM, Hughes IA, Ahmed SF. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol (Oxf). 2003; 58: 770-776.
16. International Diabetes Federation criteria 2007. Available: https://www.idf.org/metabolic-syndrome/ children.
17. Esbenshade AJ, Simmons JH, Koyama T, Lindell RB, Friedman DL. Obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy. Pediatric Blood & Cancer. 2013; 60: 1287-1291.
18. Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, Pluijm SM, Bierings MB, van den Bos C, et al. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial. J Clin Oncol. 2016; doi: 10.1200/JCO.2015.66.0761
19. Yang L, Panetta JC, Cai XJ, Yang WJ, Pei DQ, Cheng C, et al. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. Journal of Clinical Oncology. 2008; 26: 1932-1939. doi: 10.1200/JCO.2007.13.8404 PMID: 18421047
20. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Brit Med J. 2000; 320: 1240-1243. PMID: 10797032
21. National High Blood Pressure Education Program Working Group. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114: 555-576. PMID: 15286277
22. Fredriks AM, van Buuren S, Fekkes M, Verloove-Vanhorick SP, Wit JM. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice? European Journal of Pediatrics. 2005; 164: 216-222. PMID: 15662504
23. Rosner B, Prineas RJ, Loggie JMH, Daniels SR. Blood-Pressure Nomograms for Children and Adolescents, by Height, Sex, and Age, in the United-States. J Pediatr-Us. 1993; 123: 871-886.
24. Erasmus MC laboratory reference values; January 2015. Available: http://www.erasmusmc.nl/akc/ Diagnostiek/Diagnostiek/4533660/.
25. Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, Pluijm SMF, Bierings MB, van den Bos C, et al. A double blind randomised clinical trial to prevent serious side effects of dexamethasone during pediatric acute lymphoblastic leukemia treatment. Blood. 2015; 126: 2495.
26. Vaccaro O, Riccardi G. Changing the Definition of Impaired Fasting Glucose-Impact on the classification of individuals and risk definition. Diabetes Care. 2005; 28: 1786-1788. PMID: 15983335
27. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005; 115: E500-E503. PMID: 15741351
28. Global IDF/ISPAG Guideline for Diabetes in Childhood. International Diabetes Federation. 2011.
29. Brar PC, Mengwall L, Franklin BH, Fierman AH. Screening Obese Children and Adolescents for Prediabetes and/or Type 2 Diabetes in Pediatric Practices: A Validation Study. Clinical Pediatrics. 2014; 53: 771-776. doi: 10.1177/0009922814528571 PMID: 24671874
30. van der Aa MP, Farsani SF, Kromwijk LAJ, de Boer A, Knibbe CAJ, van der Vorst MMJ. How to Screen Obese Children at Risk for Type 2 Diabetes Mellitus? Clinical Pediatrics. 2014; 53: 337-342. doi: 10. 1177/0009922813509480 PMID: 24243989
31. Standards of Medical Care in Diabetes-2012. Diabetes Care. 2012; 35: S11-S63. doi: 10.2337/dc12-s011 PMID: 22187469
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis Model Assessment-Insulin Resistance and Beta-Cell Function from Fasting Plasma-Glucose and Insulin Concentrations in Man. Diabetologia. 1985; 28: 412-419. PMID: 3899825
33. Allard P, Delvin EE, Paradis G, Hanley JA, O'Loughlin J, Lavallee C, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clinical Chemistry. 2003; 49: 644-649. PMID: 12651818
34. d'Annunzio G, Vanelli M, Pistorio A, Minuto N, Bergamino L, Iafusco D, et al. Insulin resistance and secretion indexes in healthy Italian children and adolescents: a multicentre study. Diabetologia. 2009; 52: S464.
35. Russell NDF, Cooper ME. 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications. Diabetologia. 2015; 58:1708-1714. doi: 10.1007/s00125-015-3600-1 PMID: 25906755
36. Turina M, Fry DE, Polk HC. Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects. Critical Care Medicine. 2005; 33: 1624-1633. PMID: 16003073
37. Stegenga ME, van der Crabben SN, Bluemer RME, Levi M, Meijers JCM, Serlie MJ, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia, inhibits fibrinolysis during human endotoxemia. Blood. 2008; 112: 82-89. doi: 10.1182/blood-2007-11-121723PMID: 18316629
38. Faienza MF, Delvecchio M, Giordano P, Cavallo L, Grano M, Brunetti G, et al. Metabolic syndrome in childhood leukemia survivors: a meta-analysis. Endocrine. 2015; 49: 353-360. doi: 10.1007/s12020-014-0395-7 PMID: 25154516
39. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329: 977-986. PMID: 8366922
40. Centraal Bureau voor de Statistiek. Adiposity and obesity in Dutch children. 2015.
41. Kufe DW, Holland JF, Frei E, Society AC. Cancer medicine 6. Canada: BC Decker; 2003.
42. Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev. 2002; 16: 225-243. PMID: 12350366
43. Navarro-Millan I, Charles-Schoeman C, Yang S, Bathon JM, Bridges SL Jr, Chen L, et al. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum. 2013; 65: 1430-1438. doi: 10. 1002/art.37916 PMID: 23460074
44. Kawedia JD, Kaste SC, Pei DQ, Panetta JC, Cai XJ, Cheng C, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011; 117: 2340-2347. doi: 10.1182/blood-2010-10-311969 PMID: 21148812
45. Tempel DL, Leibowitz SF. Adrenal steroid receptors: interactions with brain neuropeptide systems in relation to nutrient intake and metabolism. J Neuroendocrinol. 1994; 6: 479-501. PMID: 7827618
46. Zalachoras I, Houtman R, Atucha E, Devos R, Tijssen AMI, Hu P, et al. Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. P Natl Acad Sci USA. 2013; 110: 7910-7915.